INTRODUCTION
The care of diabetics benefits from the patients' active participation. The family doctor, being familiar with the patient's environment and way of life, would seem to be the obvious person to assist and advise the patient in his attempts at losing weight and improving the regulation of the diabetes. He is in a position to judge what factors might impede adequate treatment.
In The Netherlands, the majority of general practitioners and internists consider treatment and care of diabetes type II patients to be the task of-the GP, although there is doubt about the possibility of adequate diabetes control in family practice." In order to investigate the possibility of achieving adequate diabetes control in every day practice, we implemented a protocol for the care of patients with type II diabetes in eight solo general practices (four experi- mental, four controls). The aim of the protocol was to bring the care of these patients as close as possible to their own living environment. Patients under internists' care were referred to their GPs.
Patients under the GP's care were offered the opportunity to practice home blood glucose monitoring. They were instructed to monitor their blood glucose when they did not feel quite fit or after abnormal meals or just for the sake of interest. This would give them the necessary feed-back to support their behaviour change. This approach has proven to be acceptable and feasible. 2 "T hey were also instructed to call the practice nurse monthly to report their level of fasting blood glucose. Only in case of inadequate regulation was a consultation with the GP planned. Self-monitoring therefore offered the opportunity to minimize the clink visits for patients with good metabolic control and to improve control for patients with insufficient diabetes regulation.
A detailed therapeutic protocol was introduced, with emphasis on weight reduction and restricted prescription of oral antidiabetic agents.
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To evaluate this type of care, answers were sought to the following questions: (1) Is the protocol feasible with regard to the process of referring, self-monitoring, consultation frequency and the prescription of medication? (2) What is the effect of this form of diabetes care on the patients' body weight and the regulation of their diabetes?
METHODS

Practices
The eight practices included were selected from a total of 57 practices of which detailed information was available from earlier studies.
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Selection was based on the following characteristics: traceability of the diabetes in the record index; percentages of referrals to internists; numbers of prescriptions of oral hypoglycaemic agents; practice list; distance to the nearest hospital; sex and age distribution of the practice population.
These variables were divided into quartiles. To select practices that did not have an extremely high or low level of care, practices were chosen from the two middle quartiles and were matched and randomly assigned to experimental and control groups. However, in spite of this procedure, at the start of the study the practices turned out to have rather differing starting-points. 6 The registered diabetes prevalence was 19.6/1000 patients in the experimental group and 21.5/1000 patients in the control practices.
Patients
All patients studied had been treated for type II diabetes for at least 6 months.
Patients younger than 40 and older than 75 years were excluded, as were patients treated with insulin or under treatment of an internist for diseases other than diabetes (with the exception of hypertension and/or obesity).
From the 171 invited patients, identified from the record index 7 ,149 participated in the study: 66 of these were in the experimental group.
Of these, 33 proved to be able to carry out accurate self-monitoring (subgroup 1). The 20 patients unwilling or incapable of self-monitoring (subgroup 2) were treated according to the same monitoring schedule as were the 13 patients who had up to then been under specialist care (subgroup 3).
Ten patients did not complete the study. At the start of the study their mean body weight (79.6 kg) differed significantly from that of the patients who completed the study (73.3 kg; p<0.05), but the diabetes regulation was equal to that of the latter group (mean HbAl 9.65%). Of these four died, two patients were referred to an internist, two patients were not motivated to adhere to the protocol, one moved out of the practice and one was admitted to hospital for a psychiatric disorder.
In the control practices (83 patients) patients either remained under conventional GP care (subgroup 4), or under specialist care (subgroup 5). Two patients died and eight were not willing to undergo the final assessment. The mean body weight at the start of the study of these drop-outs (80.1kg) differed from that of the patients who completed the study (76.8 kg; p<0.05), but the regulation of their diabetes did not (mean HbAl 9.29% vs. 8.88%).
Intervention
In a period of about 12 months in the experimental practices two different procedures were followed.
Patients who accepted the opportunity of self-monitoring were given instruction on 2-5 occasions. Selfmonitoring was carried out with Haemo-Glukotest 20-800 strips, and considered correct if deviation from the reflectometer, which was present in the practice, (Reflolux I, Boehringer Mannheim) did not exceed one scale unit. Patients adopting self-monitoring contacted the practice nurse monthly to state the level of fasting blood glucose. In case of a level >10 or <4.4 mmol/1 they consulted the GP.
While the regulation of the diabetes was insufficient new appointments were made within 2-3 weeks. After 6 months, all self-monitoring patients consulted the GP.
Patients under GP care (subgroups 2 and 3) consulted their doctors at least four times per year, at a frequency partly dependent on the regulation of the diabetes, and partly on choice. During each consultation the patient was informed of his current blood glucose level, the necessity of good regulation of the diabetes, and the importance of loss of weight in combination with physical exercise. Together with the patient the therapeutic goals were determined and solutions were sought for possible problems concerning diet and medication. Overweight patients were referred to a dietician, unless there had been a consultation in the past year.
For all patients in the experimental group a therapeutic scheme was used with fixed targets for weight and regulation and with emphasis on loss of body weight (Figure 1) .
A phased therapeutic plan was introduced, as follows: (1) no medication; (2) tolbutamide, up to 2000 mg maximally, in two doses; (3) glibenclamide, with a maximum of 15 mg, in two doses; (4) glibenclamide plus metformin, with a maximum of 3 x 500 mg or 2 x 850 mg. Fasting blood glucose levels >10 mmol/1, in spite of diet and maximal doses of oral hypoglycaemic agents were an indication for referral to an internist.
In the control practices the procedure deviated from the intervention to a varying degree. In two of them a reflectometer was available to determine capillary blood glucose levels. No control practice used fixed check-up appointments. Patients were not instructed in self-monitoring. 
Measurements
An initial and, 1 year later, a final assessment were carried out. In the experimental practices this was done by the practice nurses, prior to the patient's consultation with the GP. In the control practices the assessments were carried out by specially trained physicians, independently of a consultation with the patient's own GP.
The protocol was thought feasible if at the end of the year it would appear that: (1) most patients who had the opportunity of self-monitoring had accepted this, and were able to carry it out accurately; (2) the consultation frequency according to the protocol had really appeared; (3) patients had been referred to a dietician or an internist according to the protocol; (4) the physicians had followed the instructions of the therapeutic scheme, the intervention had not resulted in increased use of oral hypoglycaemic agents and after increase of medication regulation of the diabetes had improved.
All consultations with the general practitioner were systematically recorded. To assess feasibility, all completed forms from the 66 patients who started the study were checked.
The effects of the diabetes care protocol could be measured in only those patients, who completed the study. The mean body weight and HbAl in initial and final assessments were compared; the difference between both groups in mean changes of body weight and diabetes regulation was tested; and the changes of body weight and/or diabetes regulation, expressed in increase/decrease and in change in categories of the Quetelet index (<27 = acceptable, 27-30 = overweight, >30 = obesity) and HbAl percentage (<8 = good, 8-10 = reasonable, >10 = insufficient) were compared.
The differences between the subgroups were not tested separately", because of the small numbers of patients in some of them. All patients were weighed on calibrated scales. All HbAl measurements were carried out in the Laboratory of the University Hospital, by means of micro-column(R) chromatography (normal values 5.3-7.7%). 
Statistical analysis
The comparison of mean initial and final assessments in both groups was done with Student's f-test for unpaired data. With respect to the mean individual changes of body weight and diabetes regulation both groups were compared by means of a multivariate analysis of variance. Because intervention and control groups differed significantly as to base-line regulation of the diabetes and its duration (Table 1) , these variables were checked for confounding.
Only the regulation at the start of the study appeared to be related to changes in diabetes regulation (Pearson correlation coefficient 0.53) and with body weight development (Pearson correlation coefficient 0.24). Therefore the results were adjusted accordingly. X 2 tests or Fisher's exact tests were used to compare the individual changes in categories of body weight or diabetes regulation (nominal variables). A 95% reliability level for statistical significance and 95% confidence limits were used.
RESULTS
Feasibility
Self-monitoring by means of blood glucose sticks proved to be feasible for 33 of the 53 selected patients (62%). No patient of this subgroup dropped out.
For 42% of the patients with self-monitoring a halfyearly visit to the GP was sufficient ( Table 2) . The relationship between the number of clinic visits and the changes in blood glucose control, which could be expected from the protocol criteria, really appeared. With a frequency of two visits per year HbAl decreased in 31% of the patients, with three or four visits in 35%, and with five or more in 79% of the patients (p<0.005).
Only two overweight patients were not referred to a dietician. This happened according to the protocol. Two patients were referred to an internist, but not according to the protocol. One of them asked for 'the same care' as before the start of the study, the other was referred without reason.
With the exception of six cases, the physicians adhered to the therapeutic scheme. Contrary to the protocol the patient's medication was increased in four cases, in one case it was not reduced, and in one case it was reduced at the patient's explicit request. The intervention did not result in increased use of oral hypoglycaemic agents: in the experimental practices, 64% of the patients remained on unchanged therapy; in the control practices this figure was 78% (n.s.) .
Medication change according to the protocol was related to a decrease in HbAl. For the patients whose therapy remained unchanged, HbAl decreased in 34%, for patients who started taking (stronger) medication in 79%, for patients whose medication was reduced in 0% (p<0.005).
Protocol effect on body weight
The mean patients' body weight in the intervention group was reduced from 73.3 kg (SD ± 15.3) to 72.9 kg (SD ± 14.9) (n.s.). In patients in the control group it changed from 76.7 kg (SD ± 13.0) to 76.8 kg (SD ± 12.7) (n.s.). The results in the subgroups were not significant. The mean individual changes in body weight did not differ between both groups (Table 3) .
Almost 90% of the patients in both groups with an initial QI <27 or with a QI >30 remained in the same category of body weight. In the category of patients with a QI between 27 and 30, 38% of patients in the intervention group changed to a QI <27 in the final assessment, compared with 10% in the control group (n.s.).
Protocol effect on diabetes regulation
No initial HbAl assessment could be carried out in two of the 129 patients (one in each group).
Mean HbAl decreased in the experimental group (n=55) from 9.7% to 9.2% (SD ± 1.49; CL 8.8-9.6; p<0.05), whereas it increased in the control group (w=72) from 8.9% to 9.4% (SD ± 1.14; CL 9.2-9.7; p<0.001). In all subgroups in the experimental prac- In the control practices HbAl increased significantly in both subgroups: subgroup 4: +0.41, SD ± 1.03 (CL 0.14-0.68); subgroup 5: +0.98, SD ± 1.39 (CL 0.32-1.64). After adjusting for the diabetes regulation at the start of the study, the difference in mean individual change between both groups remained significant (Table 3) .
In the experimental practices HbAl decreased in two patients with an initial HbAl <8 (14%), whereas in the control practices it remained the same or increased in all patients of this category (n.s.). In the experimental practices, HbAl decreased in 80% of the patients with an initial value of >10, in contrast to 53% in the control practices (n.s.).
As Table 4 shows, 14 patients in the experimental group with an initial HbAl >10 shifted to the category of 8-10. In this category, the difference between intervention and control group is significant.
Protocol effect on body weight and regulation
Of the patients in the control practices, 34 improved neither in weight, nor in regulation. In the intervention group, on the other hand, 18 patients achieved a lower body weight as well as a reduction of HbAl (Table 5 ). DISCUSSION Self-monitoring proved to be feasible for the majority of selected patients. The number of adequate referrals to the dietician, the low number of dropouts and referrals not according to protocol as well as adherence to the therapeutic scheme showed that the protocol was feasible for both general practitioners and patients. The relation between consultation frequency and change in diabetes regulation also supports the feasibility of the protocol.
Thus, on the one hand patients with a fasting glucose level <10mmol/l were able to reduce their consultation frequency, while on the other hand the protocol urged patients with inadequately regulated diabetes to increase their consultation frequency. This led not only to enhanced self-care but also to improved diabetes control.
To measure the effects of the protocol, we were obliged to exclude all the patients who did not complete the study, and we cannot comment on their responses to the protocol.
The relation found between the use of stronger oral hypoglycemic therapy and an improved diabetes regulation is in agreement with the findings from another study. 8 This could imply that the effects of the protocol might be improved by tightening up the criteria for treatment.
Our study covers only eight general practices. Unfortunately the selection criteria for matching the practices did not include the regulation of the diabetes at the start of the study. Nevertheless, by adjusting for the starting levels of the regulation and the differences between practices, the overall protocol effect could be measured.
The patients studied lost very little weight. Maximum emphasis on weight reduction should probably be applied over a shorter period, but more intensively.
•' Probably the dietician should be more closely involved. In a number of studies in diabetes type II patients more substantial weight reduction' 1 or greater improvements in the regulation of the diabetes 8 '"' 12 were obtained. In others the results were comparable 1314 or worse. 15 In all the above mentioned studies additional activities outside the normal medical care contacts were carried out, and sometimes the protocol required the prescription of stronger medication.
8|1U2 Our protocol, by contrast, aimed at making diabetes check-ups fit into everyday practice. Its good results can be attributed to a combination of greater participation of the patient, the consultation frequency determined per individual patient, and the prescription of oral hypoglycaemic agents according to body weight changes.
